サンプル依頼リスト カート
  • English
  • Korean
表紙：甲状腺眼症市場レポート：2030年までの動向、予測、競合分析
市場調査レポート
商品コード
1356893

甲状腺眼症市場レポート：2030年までの動向、予測、競合分析

Thyroid Eye Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

甲状腺眼症市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

甲状腺眼症の動向と予測

世界の甲状腺眼症市場は、2024年から2030年までのCAGRが8.1％で、2030年までに推定14億米ドルに達すると予想されます。この市場の主な促進要因は、自己免疫疾患治療の増加、治療に対する患者のコンプライアンスの増加、ヘルスケア環境の改善です。世界の甲状腺眼症市場の将来は、病院や診療所市場における機会によって有望視されています。

甲状腺眼症市場の洞察

  • Lucintelは、モノクローナル抗体が予測期間中に最も高い成長を遂げると予測しています。
  • この市場において、病院は最大のセグメントであり続けるでしょう。
  • APAC地域は、ヘルスケア支出の増加、疾患数の増加、同地域の主要企業による投資の増加により、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の甲状腺眼症市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の甲状腺眼症市場動向（2018-2023）と予測（2024-2030）
  • 治療タイプ別：世界の甲状腺眼症市場
    • コルチコステロイド
    • ビタミン
    • モノクローナル抗体
    • その他
  • 投与経路別：世界の甲状腺眼症市場
    • 経口
    • 局所
    • 非経口
  • 製品別：世界の甲状腺眼症市場
    • 錠剤
    • カプセル
    • 軟膏
    • ソリューション
  • 最終用途産業別：世界の甲状腺眼症市場
    • 病院
    • クリニック
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の甲状腺眼症市場
  • 北米の甲状腺眼症市場
  • 欧州の甲状腺眼症市場
  • アジア太平洋甲状腺眼症市場
  • その他地域甲状腺眼症市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
  • 世界の甲状腺眼症市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の甲状腺眼症市場の能力拡大
    • 世界の甲状腺眼症市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • AbbVie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi S.A.
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare
目次

Thyroid Eye Disease Trends and Forecast

The future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

A more than 150-page report is developed to help in your business decisions.

Thyroid Eye Disease by Segment

The study includes a forecast for the global thyroid eye disease by treatment type, route of administration, product, end use industry, and region.

Thyroid Eye Disease Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Corticosteroids
  • Vitamins
  • Monoclonal Antibody
  • Others

Thyroid Eye Disease Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Topical
  • Parenteral

Thyroid Eye Disease Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Tablet
  • Capsule
  • Ointment
  • Solution

Thyroid Eye Disease Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Thyroid Eye Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Thyroid Eye Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid eye disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid eye disease companies profiled in this report include-

  • Abbvie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi S.A.
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare

Thyroid Eye Disease Market Insights

  • Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
  • Within this market, hospitals will remain the largest segment.
  • APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Features of the Global Thyroid Eye Disease Market

  • Market Size Estimates: Thyroid Eye Disease Market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Thyroid Eye Disease Market by various segments, such as by treatment type, route of administration, product, end use industry and region in terms of($B).
  • Regional Analysis: Thyroid Eye Disease Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different treatment types, route of administrations, products, end use industries, and region.s for the thyroid eye disease market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid eye disease market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the thyroid eye disease market size?

Answer: The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030.

Q.2. What is the growth forecast for thyroid eye disease market?

Answer: The global thyroid eye disease market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the thyroid eye disease market?

Answer: The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

Q.4. What are the major segments for thyroid eye disease market?

Answer: The future of the thyroid eye disease market looks promising with opportunities in the hospital and clinic markets.

Q.5. Who are the key thyroid eye disease market companies?

Answer: Some of the key thyroid eye disease companies are as follows:

  • AbbVie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi S.A.
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare

Q.6. Which thyroid eye disease market segment will be the largest in future?

Answer: Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.

Q.7. In thyroid eye disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the thyroid eye disease market by treatment type (corticosteroids, vitamins, monoclonal antibody, and others), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Thyroid Eye Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Thyroid Eye Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Thyroid Eye Disease Market by Treatment Type
    • 3.3.1: Corticosteroids
    • 3.3.2: Vitamins
    • 3.3.3: Monoclonal Antibody
    • 3.3.4: Others
  • 3.4: Global Thyroid Eye Disease Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Topical
    • 3.4.3: Parenteral
  • 3.5: Global Thyroid Eye Disease Market by Product
    • 3.5.1: Tablet
    • 3.5.2: Capsule
    • 3.5.3: Ointment
    • 3.5.4: Solution
  • 3.6: Global Thyroid Eye Disease Market by End Use Industry
    • 3.6.1: Hospitals
    • 3.6.2: Clinics
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Thyroid Eye Disease Market by Region
  • 4.2: North American Thyroid Eye Disease Market
    • 4.2.1: North American Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.2.2: North American Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.3: European Thyroid Eye Disease Market
    • 4.3.1: European Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.3.2: European Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.4: APAC Thyroid Eye Disease Market
    • 4.4.1: APAC Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.4.2: APAC Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.5: ROW Thyroid Eye Disease Market
    • 4.5.1: ROW Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.5.2: ROW Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Thyroid Eye Disease Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Thyroid Eye Disease Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Thyroid Eye Disease Market by Product
    • 6.1.4: Growth Opportunities for the Global Thyroid Eye Disease Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Thyroid Eye Disease Market by Region
  • 6.2: Emerging Trends in the Global Thyroid Eye Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Thyroid Eye Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Eye Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AbbVie
  • 7.2: Novartis International
  • 7.3: Teva Pharmaceutical Industries
  • 7.4: Pfizer
  • 7.5: Sanofi S.A.
  • 7.6: Merck
  • 7.7: Abbot Laboratories
  • 7.8: Horizon Therapeutics
  • 7.9: Johnson & Johnson
  • 7.10: GE Healthcare